Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research
Maria R. Dauvermann, Graham Lee, Neil Dawson
British Journal of Pharmacology (2017) Vol. 174, Iss. 19, pp. 3136-3160
Open Access | Times Cited: 77

Showing 26-50 of 77 citing articles:

Deconstructing Schizophrenia: Advances in Preclinical Models for Biomarker Identification
Judith A. Pratt, Brian Morris, Neil Dawson
Current topics in behavioral neurosciences (2018), pp. 295-323
Open Access | Times Cited: 20
GLYX-13 Ameliorates Schizophrenia-Like Phenotype Induced by MK-801 in Mice: Role of Hippocampal NR2B and DISC1
Dongsheng Zhou, Dan Lv, Zhen Wang, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 20
Ketamine Restores Thalamic-Prefrontal Cortex Functional Connectivity in a Mouse Model of Neurodevelopmental Disorder-Associated 2p16.3 Deletion
Rebecca Hughes, Jayde Whittingham‐Dowd, Rachel E Simmons, et al.
Cerebral Cortex (2019) Vol. 30, Iss. 4, pp. 2358-2371
Open Access | Times Cited: 17
Frontal neural metabolite changes in schizophrenia and their association with cognitive control: A systematic review
Bradley J. Dixon, Jyothika Kumar, Claudia Danielmeier
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 224-247
Open Access | Times Cited: 14
Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor signalling in the PFC, but not in the hippocampus, and disturbs PFC-dependent cognition in mice
Sara R. Tanqueiro, Francisco M. Mouro, Catarina B. Ferreira, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 6, pp. 730-743
Open Access | Times Cited: 13
A review on the role of metabotropic glutamate receptors in neuroplasticity following psychostimulant use disorder
Roghayeh Mozafari, Saeideh Karimi‐Haghighi, Mojdeh Fattahi, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 124, pp. 110735-110735
Closed Access | Times Cited: 5
Glutamine antagonism attenuates physical and cognitive deficits in a model of MS
Kristen R. Hollinger, Matthew D. Smith, Leslie A. Kirby, et al.
Neurology Neuroimmunology & Neuroinflammation (2019) Vol. 6, Iss. 6
Open Access | Times Cited: 15
Alterations in NMDAR-mediated signaling within the laterodorsal tegmental nucleus are associated with prenatal nicotine exposure
Filip S. Polli, Kristi A. Kohlmeier
Neuropharmacology (2019) Vol. 158, pp. 107744-107744
Closed Access | Times Cited: 14
Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders
Tooran Nayeri, Shahabeddin Sarvi, Ahmad Daryani
Metabolic Brain Disease (2021) Vol. 37, Iss. 1, pp. 123-146
Closed Access | Times Cited: 12
Anticancer and Neuroprotective Activities of Ethyl Acetate Fractions from Morus macroura Miq. Plant Organs with Ultraperformance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Profiling
Dalia I. Hamdan, Samia Salah, Wafaa H. B. Hassan, et al.
ACS Omega (2022) Vol. 7, Iss. 18, pp. 16013-16027
Open Access | Times Cited: 8
Augmenting cognitive work: a review of cognitive enhancement methods and applications for operational domains
Alexandre Marois, Daniel Lafond
Cognition Technology & Work (2022) Vol. 24, Iss. 4, pp. 589-608
Closed Access | Times Cited: 8
NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites
Paul Goldsmith
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 24, pp. 2239-2253
Closed Access | Times Cited: 13
Map2k7 Haploinsufficiency Induces Brain Imaging Endophenotypes and Behavioral Phenotypes Relevant to Schizophrenia
Rebecca L. Openshaw, David M. Thomson, Rhiannon Thompson, et al.
Schizophrenia Bulletin (2019) Vol. 46, Iss. 1, pp. 211-223
Open Access | Times Cited: 12
Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction
Laura L. Giacometti, Jacqueline M. Barker
Brain Research (2019) Vol. 1723, pp. 146390-146390
Open Access | Times Cited: 12
Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile
Simon E. Ward, Mark H Harries, Laura Aldegheri, et al.
Journal of Psychopharmacology (2019) Vol. 34, Iss. 1, pp. 93-102
Open Access | Times Cited: 12
Retinal function and preclinical risk traits in children and adolescents at genetic risk of schizophrenia and bipolar disorder
Michel Maziade, Alexandre Bureau, Valérie Jomphe, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 112, pp. 110432-110432
Closed Access | Times Cited: 11
Aripiprazole combined with nerve growth factor improves cognitive function in mice with schizophrenia model
Cailian Lu, Shan Li, Lin Kang, et al.
Neuroscience Letters (2023) Vol. 812, pp. 137410-137410
Closed Access | Times Cited: 4
Are working memory and glutamate concentrations involved in early‐life stress and severity of psychosis?
Mark Corcoran, Emma L. Hawkins, Denis O’Hora, et al.
Brain and Behavior (2020) Vol. 10, Iss. 6
Open Access | Times Cited: 11
The phosphodiesterase-4 and glycine transporter-1 inhibitors enhance in vivo hippocampal theta network connectivity and synaptic plasticity, whereas D-serine does not
A. Ahnaou, T. Broadbelt, R. Biermans, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Neurotransmitters and molecular chaperones interactions in cerebral malaria: Is there a missing link?
Michael Oluwatoyin Daniyan, Funmilola A. Fisusi, Adeoye Bayo Olufunso
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 7
Verbal working memory and functional large-scale networks in schizophrenia
Maria R. Dauvermann, Thomas WJ Moorhead, Andrew Watson, et al.
Psychiatry Research Neuroimaging (2017) Vol. 270, pp. 86-96
Open Access | Times Cited: 10
Detection of Morphological Abnormalities in Schizophrenia: An Important Step to Identify Associated Genetic Disorders or Etiologic Subtypes
Anne-Clemence Priol, Laure Denis, Gaëlla Boulanger, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9464-9464
Open Access | Times Cited: 9
Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study
Shinnyi Chou, Kenneth N. Fish, David A. Lewis, et al.
Neurobiology of Disease (2023) Vol. 185, pp. 106262-106262
Open Access | Times Cited: 3
Synthesis and Biological Evaluation of Novel 2,3-disubstituted Benzofuran Analogues of GABA as Neurotropic Agents
Arturo Coaviche-Yoval, Héctor Luna, Ricardo Tovar-Miranda, et al.
Medicinal Chemistry (2018) Vol. 15, Iss. 1, pp. 77-86
Closed Access | Times Cited: 8
Computer Simulations Predict High Structural Heterogeneity of Functional State of NMDA Receptors
Anton V. Sinitskiy, Vijay S. Pande
Biophysical Journal (2018) Vol. 115, Iss. 5, pp. 841-852
Open Access | Times Cited: 8

Scroll to top